Dr. Jennifer Kungle, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5012 Dorsey Hall Dr, Suite 105, Ellicott City, MD 21042 Phone: 410-730-8878 Fax: 410-997-8282 |
Dr. Ann Marie Gallagher, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8450 Baltimore National Pike Ste 155, Ellicott City, MD 21043 Phone: 410-465-6166 Fax: 410-465-8898 |
Michael L. Schwartz, OD Optometrist Medicare: Medicare Enrolled Practice Location: 10050 Baltimore National Pike, Suite F 100, Ellicott City, MD 21042 Phone: 410-461-2020 Fax: 410-461-2387 |
Professional Vision Of Ellicott City, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 8450 Baltimore National Pike Ste 155, Ellicott City, MD 21043 Phone: 410-465-6166 |
Cho & Cho Professional, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 8815 Baltimore National Pike, Suite A, Ellicott City, MD 21043 Phone: 410-461-8606 Fax: 410-461-8604 |
News Archive
Food insecurity is a major problem in the U.S., and it worsened during the COVID-19 pandemic. The Supplemental Nutrition Assistance Program provides some relief, but millions of Americans still lack adequate access to healthy food. A new study from the University of Illinois proposes a potential solution.
Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the U.S. Food and Drug Administration designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive mucormycosis (also known as zygomycosis), a life-threatening invasive fungal infection caused by certain emerging molds.
An accumulation of a protein called amyloid-beta into large insoluble deposits called plaques is known to cause Alzheimer's disease. One aspect of this illness that has not received much attention is which role the structure of the brain environment plays.
Royal Philips Electronics, in partnership with the American College of Cardiology, spotlight the growing need for minimally-invasive interventions to address a spectrum of cardiac conditions, such as structural and degenerative heart issues. The need to reduce invasive surgical interventions and complication rates is driving innovations in minimally invasive approaches.
› Verified 9 days ago